Brief: Avid Bioservices Announces Further Expansion Of Process Development Capacity For Mammalian Cell Business
13/06/2022 13:26
June 13 (Reuters) - Avid Bioservices Inc CDMO.O :
* AVID BIOSERVICES ANNOUNCES FURTHER EXPANSION OF PROCESS
DEVELOPMENT CAPACITY FOR MAMMALIAN CELL BUSINESS
* AVID BIOSERVICES INC - EXPANSION TO COST APPROXIMATELY $6
MILLION WITH COMPLETION ANTICIPATED BY END OF CALENDAR 2022
Source text for Eikon: ID:nGNXLR41T
Further company coverage: CDMO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Avid Bioservices
See all newsBrief: Avid Bioservices Recommends Stockholders Vote For Value Maximizing Transaction
Avid Bioservices Inc reports results for the quarter ended October 31 - Earnings Summary
U.S. RESEARCH ROUNDUP- Autozone, Costco Wholesale, Salesforce
Press Digest: Wall Street Journal - Nov. 7
Brief: Avid Bioservices to be acquired for $1.1 bln by GHO Capital Partners, Ampersand Capital Partners